Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria

To study the mechanisms of protection against endotoxin challenge offered by antisera to smooth and rough gram-negative organisms, we have developed an assay to quantitate endotoxin neutralization based on inhibition of the Limulus amoebocyte lysate test. Dilutions of different bacterial lipopolysaccharides (LPSs) were incubated with hyperimmune rabbit sera against Escherichia coli O113, E. coli O18, and rough mutants E. coli J5 and Salmonella minnesota Re595 and were then combined with limulus lysate. The gelation reaction induced by LPS in the lysate was monitored spectrophotometrically, and the concentration of LPS resulting in a 50% lysate response was determined and correlated with antibody titers measured by enzyme-linked immunosorbent assay. Antisera to smooth organisms neutralized homologous LPS markedly and heterologous LPSs only minimally relative to neutralization by preimmune serum. Neutralization of homologous LPS occurred immediately without preincubation of serum and LPS. Antisera to rough mutants neutralized more heterologous LPS than did antisera to smooth organisms. However, this heterologous neutralization required preincubation of serum and LPS and did not appear to be correlated with antibody concentrations. We conclude that antisera to LPS rapidly neutralize the biological activity of the homologous LPS, as detected by limulus lysate, and that neutralization is at least in part antibody mediated. Antisera to rough-mutant organisms slowly neutralized the activity of heterologous LPSs, but this effect appeared not to be correlated with concentrations of antibody to the LPS of the rough mutant, as measured by enzyme-linked immunosorbent assay.

[1]  C. Dinarello,et al.  Role of interleukin-1 in augmenting serum neutralization of bacterial lipopolysaccharide , 1987, Journal of clinical microbiology.

[2]  H. S. Warren,et al.  Neutralization and lipoprotein binding of lipopolysaccharides in tolerant rabbit serum. , 1986, The Journal of infectious diseases.

[3]  R. Ulevitch,et al.  Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum , 1986, The Journal of experimental medicine.

[4]  H. S. Warren,et al.  Neutralization of bacterial lipopolysaccharides by human plasma , 1985, Journal of clinical microbiology.

[5]  H. S. Warren,et al.  Turbidimetric method for quantifying serum inhibition of Limulus amoebocyte lysate , 1985, Journal of clinical microbiology.

[6]  R. Ulevitch,et al.  Control of lipopolysaccharide-high density lipoprotein binding by acute phase protein(s). , 1983, Journal of immunology.

[7]  A. Lindberg,et al.  Induction of endotoxin tolerance with nonpyrogenic O-antigenic oligosaccharide-protein conjugates , 1983, Infection and immunity.

[8]  W. R. Mccabe,et al.  Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin. , 1983, The Journal of infectious diseases.

[9]  J. McCutchan,et al.  TREATMENT OF GRAM-NEGATIVE BACTEREMIA AND SHOCK WITH HUMAN ANTISERUM TO A MUTANT ESCHERICHIA COLI , 1983 .

[10]  J. Lipton,et al.  Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. , 1982, The Journal of clinical investigation.

[11]  J. Pennington,et al.  Type-specific vs. cross-protective vaccination for gram-negative bacterial pneumonia. , 1981, The Journal of infectious diseases.

[12]  J. Boslego,et al.  A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies. , 1981, JIM - Journal of Immunological Methods.

[13]  A. Nowotny,et al.  Immunization Against Bacteria- and Endotoxin-Induced Hypotension , 1981, Infection and immunity.

[14]  R. Ulevitch,et al.  New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. , 1981, The Journal of clinical investigation.

[15]  C. J. Webster Principles of a quantitative assay for bacterial endotoxins in blood that uses Limulus lysate and a chromogenic substrate , 1980, Journal of clinical microbiology.

[16]  D. Dubose,et al.  Comparison of plasma extraction techniques in preparation of samples for endotoxin testing by the Limulus amoebocyte lysate test , 1980, Journal of clinical microbiology.

[17]  S. E. Greisman,et al.  Experimental gram-negative bacterial sepsis: prevention of mortality not preventable by antibiotics alone , 1979, Infection and immunity.

[18]  R. Ulevitch,et al.  The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum. , 1978, The Journal of clinical investigation.

[19]  S. E. Greisman,et al.  Experimental Gram-Negative Bacterial Sepsis: Reevaluation of the Ability of Rough Mutant Antisera to Protect Mice 1 , 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[20]  E. Ziegler,et al.  Neutralization of meningococcal endotoxin by antibody to core glycolipid , 1978, The Journal of experimental medicine.

[21]  P. Ward,et al.  Isolation from human serum of an inactivator of bacterial lipopolysaccharide. , 1977, The American journal of pathology.

[22]  A. Nowotny,et al.  Relationship of structure to function in bacterial endotoxins: serologically cross-reactive components and their effect on protection of mice against some gram-negative infections. , 1976, Journal of general microbiology.

[23]  E. Milner,et al.  Preparation and properties of a national reference endotoxin , 1976, Journal of clinical microbiology.

[24]  L. Young Opsonizing antibodies, host factors, and the limulus assay for endotoxin , 1975, Infection and immunity.

[25]  M. Wilson,et al.  Protection Against Gram-Negative Infections with Antiserum to Lipid A from Salmonella minnesota R595 , 1974, Infection and immunity.

[26]  E. J. Young,et al.  Mechanisms of endotoxin tolerance. 8. Specificity of serum transfer. , 1973, Journal of immunology.

[27]  A. Braude,et al.  Treatment and prevention of intravascular coagulation with antiserum to endotoxin. , 1973, The Journal of infectious diseases.

[28]  G. A. Hébert,et al.  Determination of the optimal ammonium sulfate concentration for the fractionation of rabbit, sheep, horse, and goat antisera. , 1973, Applied microbiology.

[29]  A. Braude,et al.  Passive immunization against the local Shwartzman reaction. , 1972, Journal of immunology.

[30]  C. Galanos,et al.  Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides. , 1971, European journal of biochemistry.

[31]  A. van Dalen,et al.  Isolation and some properties of rabbit IgM immunoglobulin. , 1967, Biochimica et Biophysica Acta.

[32]  E. J. Young,et al.  MECHANISMS OF ENDOTOXIN TOLERANCE , 1966, Journal of Experimental Medicine.

[33]  W. W. Wells,et al.  PROTECTION AGAINST LETHALITY OF E. COLI ENDOTOXIN WITH “O” ANTISERUM * , 1966, Annals of the New York Academy of Sciences.

[34]  F. Rosen,et al.  Inactivation of Biologically Active (“Endotoxic”) Polysaccharides by Fresh Human Serum , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.